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A genetic locus affecting susceptibility to the bactericidal activity of normal
human serum has been designated sac-i. This locus was shown to be closely
linked to, but not identical with, a second locus (designated nmp-2) that affects
protein 1 of the outer membrane. The sac-I locus could be linked to known
antibiotic resistance markers on the gonococcal chromosome by genetic transfor-
mation.
A correlation between virulence and resist-
ance to the bactericidal activity ofhuman serum
has been observed for several different gram-
negative organisms, including Escherichia coli
(20) and Pseudomonas aeruginosa (23). Strains
isolated from the blood are usually serum resist-
ant, whereas isolates from stool, urine, or mu-
cosal surfaces are often sensitive to killing by
serum. This relationship also has been shown to
exist for infections caused by Neisseria gonor-
rhoeae. Strains that cause disseminated gono-
coccal infection are usually penicillin sensitive
(22), exhibit unusual nutritional requirements
(9), and are serum resistant (14). In contrast,
gonococcal strains that produce local inflam-
mation are frequently serum sensitive (1). In an
epidemiological study, Eisenstein et al. (3)
showed that the ability to cause disseminated
disease correlates with two independent prop-
erties: penicillin sensitivity and serum resistance.
These observations suggest that the property of
serum resistance may be an important factor in
the ability ofthe gonococcus to cause bacteremic
disease.
Studies on the genetic basis of the serum
resistance of the gonococcus should be useful in
determining the relationship between serum re-
sistance and other properties of the cell and in
identifying the components of the cell surface
involved in resistance to the bactericidal action
of serum. A limited number of such studies have
been done. Mayer et al. (12) reported that ge-
netic lesions responsible for auxotrophy of
strains causing disseminated gonococcal infec-
tion are unlinked to a genetic locus for serum
resistance. Spratt et al. (18) described a genetic
locus (sac-2) that affects the level of serum
resistance. The biochemical basis for differences
in resistance due to this locus was not studied.
Hildebrandt et al. (6) reported that transforma-
tion of a serum-sensitive gonococcal strain to
serum resistance was accompanied by simulta-
neous structural and antigenic changes in pro-
tein 1 of the outer membrane (the principal
outer membrane protein). These authors sug-
gested that serum resistance of gonococci is re-
lated to the possession of a protein 1 of charac-
teristic subunit molecular weight and antigenic
structure.
In this paper, we report the identification of a
genetic locus affecting the level of serum resist-
ance of the gonococcus. This locus, designated
sac-i, was closely linked to, but not identical
with, a locus that affected protein 1.
MATERIALS AND METHODS
Strains used. The strains of N. gonorrhoeae used
in these studies are listed in Table 1. Growth condi-
tions and media have previously been described (13).
Determination of colony opacity or transparency was
made according to the procedures of Swanson (19).
Genetic transformation. Procedures for prepa-
ration of transforming deoxyribonucleic acid (DNA)
and genetic transformation were as previously de-
scribed (13). Selection of antibiotic-resistant trans-
formants was made on agar plates of GCBA-DS me-
dium (13) containing the following concentrations of
antibiotics: rifaInpin (Rif), 2 pg/ml; streptomycin (Str),
100 pLg/ml; spectinomycin (Spc), 200 pg/ml. For selec-
tion of serum-resistant transformants, serum-sensitive
competent cells were mixed with saturating amounts
of transforming DNA from a serum-resistant strain.
After incubation at 37°C with shaking for 4 to 5 h,
deoxyribonuclease (Worthington) was added to a final
concentration of 50 pg/ml, and the mixture was incu-
bated for an additional 5 min. The transformation
mixture was mixed with pooled normal human serum
(NHS), to a final serum dilution of 1:4, and incubated
for 30 to 45 min at 37°C with shaking. Survivors of
this treatment were tested for level ofserum resistance
in the standard serum bactericidal assay.
Serum bactericidal assay. The time course of
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TABLE 1. Strains of N. gonorrhoeae used
Apparent
Strain Relevant genotype Serum sus- mol wt ofceptibility' protein 1b Source
(106)
FA19 sac-lc R 36.5 A. Reyn
F62 sac-i + S 37.2 D. Kellogg
FA600 sac-i R 36.5 Serum-resistant transformant: FA19 x F62
FA671 sac-lC R 36.5 Second-step serum-resistant transformant: FA19 x
FA600
FA114 rif-i spc-3 sac-i c d R 36.5 Rifr Spcr derivative of strain FA19 (13)
FA101 str-7 sac-Ic R 36.5 Strr transformant: FA47 (17) x FA19
FA610 str-7 sac-1+ S 37.2 Strr transformant: FA101 x F62
FA630 str-r sac- 5S 37.2 Strr serum-sensitive derivative of FA19: FA610 x FA19
FA635 spc-3 sac-i + S 36.5 Spcr transformant: FA130 (Spcr derivative of FA19;
reference 13) x F62
FA140 sac-lc R 39.0 (17)
FA198 spc-3 sac-lc R 39.0 Spcr derivative of FA140 (17)
FA488 sac-i + S 37.2 mtrpenAf derivative of strain F62: FA48 (17) x F62
FA640 spc-3 sac-1 R 39.0 Spcr transformant: FA198 x FA488
a Serum-resistant strains are designated R; serum-sensitive strains are designated S.
b Apparent molecular weight of protein 1 was determined by SDS-PAGE.
'These strains contain at least one other genetic marker affecting the level of serum resistance besides the
sac-i marker.
d rif-i is a locus for rifampin resistance; spc-3 is a locus for spectinomycin resistance (13).
e str- 7 is a locus for streptomycin resistance (13).
fmtr and penA are loci for low-level penicillin resistance (17).
complement-dependent killing of gonococci by NHS
was measured by the method previously described by
Lee et al. (11). In genetic experiments, serum resist-
ance was usually scored by exposing gonococci to
different dilutions of NHS for 30 min at 37°C in wells
of microtiter trays, as described by Eisenstein et al.
(3). Results were expressed as percent survival (in
colony-forming units), compared with controls. A cul-
ture was scored as resistant to a given dilution of
serum if survival was -70%. Strains classified as serum
resistant were generally resistant to a 1:4 dilution of
normal serum; strains classified as serum sensitive
were sensitive to at least a 1:16 dilution of serum. NHS
pools were prepared from blood collected from six to
ten laboratory workers who had not been previously
infected with N. gonorrhoeae.
Isolation of outer membranes. Procedures for
cell lysis in a French pressure cell, isolation of a crude
membrane fraction, and purification of outer mem-
branes by Sarkosyl (Geigy Chemicals) extraction have
been described previously (5).
SDS-PAGE. Sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) was done by
the method of Shapiro et al. (15), as previously de-
scribed (2). The apparent molecular weight of proteins
was determined by SDS-PAGE, using reference pro-
teins of known molecular weight. A protein with an
apparent molecular weight of 36,500 is referred to as
36.5K.
RESULTS
Strain FA19 is fully serum resistant, with a
protein 1 of apparent molecular weight of 36.5K.
Strain F62 is highly sensitive to killing by NHS
and has a protein 1 of 37.2K. Figure 1 illustrates
the difference in serum sensitivity of these
strains. The serum resistance property of strain
FA19 was transferred into strain F62 by genetic
transformation, with selection made for resist-
ance to a 1:4 dilution of NHS. The resulting
transformants were more resistant to serum than
the recipient strain was, but were less resistant
than the donor strain (Fig. 1). A second genetic
transformation, with strain FA19 as the donor
and strain FA600, one of the intermediate-level
serum-resistant transformants, as the recipient,
yielded transformants that were identical to
strain FA19 in serum susceptibility (Fig. 1).
It has been reported that transparent and
opaque colony variants of a single gonococcal
strain can have different levels of susceptibility
to killing by serum (10). The differences in serum
sensitivity of strains FA19, F62, and FA600 were
not due to variations in colony opacity, since
transparent and opaque variants of each of these
strains showed similar susceptibility to serum
killing.
The proteins of the outer membrane ofseveral
of the intermediate-level serum-resistant trans-
fornants were analyzed by SDS-PAGE (Fig. 2).
Each had acquired the donor protein 1 of 36.5K,
which suggested that protein 1 might play a
direct role in serum resistance.
In further genetic experiments, however, the
difference in serum resistance between strains
FA19 and F62 was genetically separated from
the difference in protein 1 of the two strains.
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ants that acquired the 36.5K protein 1 of the
donor strain were indistinguishable in suscepti-
bility to serum killing from the serum-sensitive
recipient strain F62, which had the 37.2K protein
1 (Fig. 1). Therefore, the difference in level of
serum resistance of strains FA19 and F62 could
not be due to the difference in protein 1 between




FIG. 1. Serum antibody-complement-mediated
killing of strains of N. gonorrhoeae. Cells were incu-
bated with a 1:4 dilution ofNHS at 37°C, and extent
of survival was determined as described in the text.
Symbols: 0, strain FA19 (serum resistant, protein
16.5K); strain F62 (serum sensitive, protein 137.2K);
0, strain FA600 (intermediate-level serum-resistant
transformant, protein 136.SK); O1, strain FA671 (fully
serum-resistant transformant, protein 136.6K); A,
strain FA635 (serum-sensitive transformant, protein
136.K).
Preliminary experiments showed that the differ-
ence in serum resistance of the two strains could
be genetically linked to several antibiotic resist-
ance markers that are located in a cluster on the
gonococcal chromosome (4, 16). A genetic trans-
formation was done, with strain FA630 (rif-l+
str-7 spc-3+, serum sensitive, protein 137.2K) as
the donor. The recipient was strain FA114 (rif-
I str-7+ spc-3, serum resistant, protein 136.5K).
Streptomycin-resistant transformants were se-
lected and scored for level of serum resistance.
Transformants were also scored for apparent
molecular weight of protein 1 by SDS-PAGE of
lysates ofwhole cells. A total of 96 streptomycin-
resistant transformants were classified into four
groups: three were serun sensitive, with protein
1 of 37.2K; four were serum sensitive, with pro-
tein 1 of 36.5K; four were serum resistant, with
protein 1 of 37.2K; and 85 were serum resistant,
with protein 1 of 36.5K. All four possible com-
binations of serum resistance and protein 1 ap-
parent molecular weight were recovered, with 8
of the 96 transformants showing recombination
between serum resistance phenotype and pro-
tein 1 phenotype.
Separation of serum resistance and protein 1
phenotype of strains FA19 and F62 also occurred
when a spectinomycin-resistant (spc-3) deriva-
tive of strain FAl9 was crossed by transforma-
tion with strain F62 (data not shown). Specti-
nomycin-resistant, serum-sensitive transform-
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FIG. 2. SDS-PAGE of outer membrane proteins of
serum-sensitive and serum-resistant strains. A, strain
FA140 (serum resistant,protein 1nK); B, strain FA488
(serum sen-sitive, protein1l37.2K); C, strain FA640 (se-
rum-resistant transformant, protein 139K); D, molec-
ular weight standards [bovine serum albumin
(67,000)), ovalbumin (45,00X0), myoglobin (17,8(0)), cy-
tochrome c (12,40X))]; E, strain FA19 (serum resistatnt,
protein13.5K); F, strain F62 (serum sensitive, protein
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that affects the level of serum resistance, which
is located near the str- 7 locus on the gonococcal
chromosome, and which is independent of the
protein 1 phenotypes found in strains FA19 and
F62. We have designated this locus as sac-i
(serum antibody-complement) and have arbi-
trarily designated the allele for serum sensitivity
in strain F62 as sac-l+ and that for serum resist-
ance in strain FA19 as sac-i. The sac-i locus
was closely linked to the genetic locus responsi-
ble for the change in apparent molecular weight
of protein 1 from 36.5 to 37.2K, which we desig-
nated nmp-2 (new membrane protein).
In similar experiments, a serum-resistant
strain with a protein 1 of 39K (strain FA198)
was used as the donor of the sac-i marker to
strain F62. Most of the transformants that ac-
quired the donor serum resistance also showed
an increase in apparent molecular weight -of
protein 1 to 39K (Fig. 2). It was possible, how-
ever, to recover serum-sensitive transformants
that acquired the 39K protein 1 of strain FA198
(data not shown). Therefore, the sac-i marker
was also independent of the 39K protein 1 of
strain FA198.
The position of the sac-i locus on the gono-
coccal chromosome was determined by genetic
mapping experiments in which the rif-i, str-7,
and spc-3 antibiotic resistance loci were used as
reference markers. These loci are well charac-
terized, and their relative positions on the gon-
ococcal chromosome have been previously
established (13). Reciprocal transformation
crosses were carried out between strains FA630
(rif-l+ str-7spc-3+ sac-l+) and FA114 (rif-1 str-
7+ spc-3 sac-i). The results of these experiments
are shown in Table 2 and suggest a gene order
of rif-l-str-7-spc-3-sac-1. When rif-i was
the selected marker, there were three transform-
ants that were Riff Strr Spc8 serumr, which were
presumably generated by double crossover
events. Although this number is somewhat
higher than might be expected, the frequency of
occurrence of the other recombinant classes was
consistent only with the suggested order of these
genetic markers. The genetic map constructed
from these data is shown in Fig. 3. The positions
of the nmp-I and penB genetic loci, which are
included on the genetic map, were determined
previously (2). Due to the close linkage between
the sac-i, nmp-2, nmp-1, andpenB loci, we have
been unable to determine their relative posi-
tions, either in these experiments or in additional
mapping experiments (data not shown).
DISCUSSION
Our results show that the genetic locus we
have designated sac-i does have an effect on the
level of serum resistance of the gonococcus.
These results also illustrate the complex nature
of the mechanisms that can give rise to differ-
ences in susceptibility to serum killing. Trans-
fornation of a serum-susceptible strain to the
level of resistance of donor strain FA19 required
two separate transformation events. Strains
FAl9 and F62 must differ in at least two genetic










FIG. 3. Genetic map derived from the data in Ta-
ble 2. The numbers represent the frequency ofrecom-
bination between two genetic markers. Arrows point
from the selected donor marker to the unselected,
scored marker. Genetic markers in parentheses could
not be ordered relative to each other. Map distances
are not drawn to scale. nmp-1 is a genetic locus
affecting protein 1 of the outer membrane; penB is a
locus for relatively nonspecific, low-level antibiotic
resistance (2, 17). The sac-i (serum resistance) and
nmp-2 (altered protein 1) loci are described in the
text.
TABLE 2. Mapping order from reciprocal transformation test crosses'
Selected Unselected donor Total No. in recombinant class:
Cross marker markers colonies
1000 0100 0010 0001 tested 1000 1001 1010 1011 1100 1101 1110 1111
Recipient strain (0000): rif-I' str-7 rif-l str-7+ spc-3 sac-i 96 63 3 0 0 28 0 1 1
spc-3+ sac-I' (FA630); donor spc-3 rif-1 str-7' sac-i 100 43 12 34 11 0 0 0 0
strain DNA (1111): rif-I str-7+
spc-3 sac-1 (FA114)
Recipient strain (0000): rif-. str-7+ str-7 rif-l spc-3+ sac-l' 96 23 0 20 2 39 1 7 4
spc-3 sac-i (FA114); donor strain
DNA (1111): rif-1 str-7spc-3+
sac-I' (FA630)
a Suggested gene order: rif-l-str-7-spc-3-sac-l. "1" and "O" refer to genetic markers of the donor and recipient strains,
respectively.
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loci that can affect the level of serum resistance:
sac-i and another, as yet unidentified, genetic
locus. This conclusion is compatible with the
work of Hildebrandt et al., who also found that
transformation of a serum-sensitive strain to full
serum resistance required two transformation
events (6).
Genetic analysis proved to be useful in study-
ing the possible association of protein 1 pheno-
type with differences in serum resistance due to
sac-i. In our initial transformation experiments,
when serum-resistant transformants were se-
lected, it appeared that protein 1 might have a
role in serum resistance. When selection was
made for a linked antibiotic resistance marker,
however, it was possible to separate protein 1
phenotype from the serum resistance phenotype
of the transformants. This was shown with the
36.5, 37.2, and 39K forms of protein 1. The
apparent association of these properties was due
to the fact that the genetic loci affecting serum
resistance and protein 1 phenotype were located
close together on the gonococcal chromosome.
We do not know what mechanism is involved in
the effect of the nmp-2 locus on protein 1, but
our results showed that the action of the sac-i
locus was not dependent on the presence of a
particular allele of nmp-2. This result is not
necessarily inconsistent with that ofHildebrandt
et al. (6), who concluded that a particular form
of protein 1 might be important in serum resist-
ance. The apparent molecular weight and anti-
genicity of protein 1 vary among gonococcal
strains (7). We have identified sac-i as a locus
that is independent of the 36.5, 37.2, and 39K
forms of protein 1 used in these experiments.
However, there may be other protein 1 types
that do have an effect on the level of serum
resistance, possibly by altering the exposure of
another target antigen of bactericidal activity.
Although our results indicate that the sac-i
locus probably affects some component of the
cell other than protein 1, we do not know the
identity of the component. There have been
several reports that gonococcal lipopolysaccha-
ride is a target antigen for antibody-complement
killing (8, 21), which suggested to us that lipo-
polysaccharide might be a candidate for the
component affected by sac-i. In a preliminary
communication (4), we reported that lipopoly-
saccharide isolated from strains F62 and FA600
differed in its ability to inhibit the bactericidal
action of NHS. However, in further experiments
with additional preparations of lipopolysaccha-
ride from these two strains, as well as with
another transformant similar to FA600, we have
found the magnitude of the difference and the
amount of lipopolysaccharide required to show
that difference are variable. Also, we have been
unable to detect any structural difference in the
lipopolysaccharide from these serum-resistant
and serum-sensitive strains by SDS-PAGE, gas-
liquid chromatography (data not shown), or im-
munological methods (M. Apicella, personal
communication). These results compel us to be
cautious in implicating lipopolysaccharide as the
component that is altered in strains differing at
the sac-i genetic locus. Further studies will be
needed to resolve this question.
Genetic mapping experiments showed that the
sac-i locus could be genetically linked to, and
ordered relative to, several well-characterized
antibiotic resistance loci. The order of the rif-1,
str-7, and spc-3 genetic loci determined in these
experiments is consistent with previously pub-
lished results (13). Spratt et al. (18) have re-
cently described a genetic locus, designated sac-
2, that also maps near this region of the gono-
coccal chromosome. These authors believe that
sac-2 is located farther away from the spc locus
than an arg marker that shows 1.3% cotransfor-
mation with spc. In contrast, our results indi-
cated that the cotransformation frequency be-
tween sac-i and spc-3 was 23%. These differ-
ences in linkage values obtained in their experi-
ments and in our own suggest that sac-i and
sac-2 are different genetic loci.
It is clear that there are multiple genetic loci
that can have an effect on the level of serum
resistance of the gonococcus. Further studies
will be needed to identify the cellular compo-
nents affected by these loci and to assess their
role in the ability of the gonococcus to establish
bacteremic disease.
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